Indian Drugmaker Cited in EU for Serious GMP Violations

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) wrote up a drug manufacturer in Bangalore, India for data integrity and other serious violations observed during a December 13 inspection.
Source: Drug Industry Daily